DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
3h
StudyFinds on MSNBreakthrough blood test could transform ALS diagnosis, careFind out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
6h
News Medical on MSNStress granules as potential biomarkers for neurodegenerative diseasesStress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Her career with the #Dayton company followed her retirement as vice president at Procter & Gamble – where she executed a ...
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
Tetramethylpyrazine nitrone is safe for ALS and may slow grip strength decline, especially in younger patients.
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. Neurology , 2025; 104 (6) DOI: 10.1212/WNL.0000000000213400 Cite This Page : ...
4d
HealthDay on MSNFour Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALSFour immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophi ...
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results